GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression

NCT03198546 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Immunotherapy
CAR
GPC3 Gene Inactivation
T Cell
Squamous Cell Lung Cancer

Interventions

BIOLOGICAL: GPC3 and/or TGFβ targeting CAR-T cells

Sponsor

Second Affiliated Hospital of Guangzhou Medical University

Collaborators

[object Object]
[object Object]
[object Object]